Jan Budczies
Ruprecht-Karls-Universität Heidelberg
H-index: 62
Europe-Germany
Top articles of Jan Budczies
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
British Journal of Cancer
2024/1/8
Wilko Weichert
H-Index: 60
Jan Budczies
H-Index: 41
Erratum to" Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project":[Annals of …
Annals of oncology: official journal of the European Society for Medical Oncology
2024/1
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma
Cancer Research
2024/3/22
Leveraging Off-Target Reads in Panel Sequencing for Homologous Recombination Repair Deficiency Screening in Tumor
The Journal of Molecular Diagnostics
2024/3/22
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer
JCO Precision Oncology
2024/3
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine …
The Journal of Pathology: Clinical Research
2024/3
Real‐world data for precision cancer medicine—A European perspective
Genes, Chromosomes and Cancer
2023/9
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
Clinical Cancer Research
2023/7/5
Carsten Denkert
H-Index: 70
Jan Budczies
H-Index: 41
Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer
British Journal of Cancer
2023/6/29
Wilko Weichert
H-Index: 60
Jan Budczies
H-Index: 41
The German Network for Personalized Medicine to enhance patient care and translational research
Nature Medicine
2023/6
Structure and content of the EU-IVDR
In vitro
2023/11/1
The impact of PD-L1 expression and co-mutations on outcome of KRAS-driven non-small-cell lung cancer.
2023/6/1
Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas
Lung Cancer
2023/6/1
Die Verordnung (EU) 2017/746 (IVDR) in der Praxis: Umsetzung von Anhang I in der Pathologie
2023/11
Homogenous TP53mut-associated Tumor biology across mutation and cancer types revealed by transcriptome analysis
Cancer Research
2023/4/4
Jan Budczies
H-Index: 41
Daniel Kazdal
H-Index: 14
Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology
2023/11
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients
NPJ Precision Oncology
2023/10/20
Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications
Lung Cancer
2023/10/1
Correction: Molecular tumor diagnostics as the driving force behind precision oncology
Deutsche Medizinische Wochenschrift (1946)
2023/9/1
Daniel Kazdal
H-Index: 14
Jan Budczies
H-Index: 41
Molecular tumor diagnostics as the driving force behind precision oncology
Deutsche Medizinische Wochenschrift (1946)
2023/9/1
Jan Budczies
H-Index: 41
Co-Authors
